Table 3.
Results of hospital stay and presence of complications during hospitalization according to the presence of obesity in COVID-19 hospitalized patients.
Variable | Normal weight | Overweight | Obesity | Morbid obesity | p |
---|---|---|---|---|---|
Hospital stay length (days) | 11 (6–26) | 11 (6–16) | 10 (7–16) | 9 (6–16) | 0.93 |
ICU admission, n (%) | 24 (20) | 63 (23) | 79 (26) | 16 (24) | 0.59 |
Respiratory failure, n (%) | 81 (67) | 180 (64) | 206 (67) | 50 (76) | 0.38 |
Mechanical ventilation, n (%) | 32 (26) | 80 (29) | 99 (32) | 25 (38) | 0.32 |
Septicemia, n (%) | 20 (16) | 33 (12) | 52 (17) | 13 (20) | 0.22 |
Secondary infection, n (%) | 14 (12) | 28 (10) | 28 (9) | 8 (12) | 0.82 |
Coagulopathy, n (%) | 8 (7) | 7 (2) | 12 (4) | 3 (4) | 0.27 |
CV complication, n (%) | 3 (2) | 19 (7) | 14 (5) | 3 (4) | 0.30 |
Acute kidney injury, n (%) | 20 (16) | 55 (20) | 69 (22) | 16 (24) | 0.49 |
RRT, n (%) | 1 (1) | 7 (2) | 19 (6) | 6 (9) | 0.007 |
Type of RRT, n (%) | 0.68 | ||||
Hemodialysis | 1 (100) | 5 (72) | 13 (68) | 6 (100) | |
Peritoneal dialysis | 0 | 1 (14) | 1 (5) | 0 | |
CRRT | 0 | 1 (14) | 5 (26) | 0 | |
Death, n (%) | 46 (38) | 95 (34) | 108 (35) | 28 (42) | 0.55 |
ICU: intensive care unit; CV: cardiovascular; RRT: renal replacement therapy; CRRT: continuous renal replacement therapy.